Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Hospira, Inc.
FDA Inspection
•Hospira, Inc.•June 17, 2011

Hospira, Inc. – FDA Inspection, Jun 17, 2011

Record Details

This FDA Inspection record concerns Hospira, Inc., with an inspection on June 17, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Hospira, Inc.
Inspection Date
June 17, 2011
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · c3ca52ef-1c47-48ea-943d-8ae7fe6e1334

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
732886
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

17
  1. 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
  2. 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
  3. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  4. 21 CFR 820.30(b)Design plans - Lack of or inadequate
  5. 21 CFR 211.160(a)Deviations from laboratory control requirements
  6. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  7. 21 CFR 211.63Equipment Design, Size and Location
  8. 21 CFR 211.192Extent of discrepancy, failure investigations
  9. 21 CFR 820.20(c)Management review - defined interval, sufficient frequency
  10. 21 CFR 820.22Quality audits - Lack of or inadequate procedures

Showing 10 of 17 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Hospira, Inc.

12
DateClassificationOfficeProject area
February 7, 2025Not classifiedAtlanta District Office
November 14, 2023OAIAtlanta District Office
November 21, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 2, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 26, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 12 other inspections on the company page
Other documents for Hospira, Inc.
  • FDA Inspection 1251941 - 2025-02-07
  • FDA Inspection 1223090 - 2023-11-14
  • FDA Inspection 1110899 - 2019-11-21
  • FDA Inspection 1039547 - 2018-02-02
  • FDA Inspection 984874 - 2016-05-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hospira, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.